ADDLF Stock Chart & Stats
$16.81
$0.00(0.00%)
At close: 4:00 PM EDT
$16.81
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$11.75 - $24.52
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
$1.98B
Enterprise Value$24.54K
Total Cash (Recent Filing)$394.00M
Total Debt (Recent Filing)$5.02B
Price to Earnings (P/E)32.2
Beta0.79
Next Earnings
Oct 21, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend Yield0.39%
Share Statistics
EPS (TTM)4.89
Shares Outstanding117,877,460
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)3.56
Price to Sales (P/S)1.86
P/FCF Ratio17.50
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$16.92Price Target Upside0.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.45
Revenue Forecast (FY)$1.12B
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation & ConversionConsistent high cash conversion and solid operating cash flow demonstrate durable earnings quality and internal funding capacity. This supports sustained dividend/M&A funding, deleveraging and reinvestment in services and aftermarket, improving long-term financial flexibility versus peers.
Sustained Margin ExpansionBroad-based margin improvement across quarters and segments reflects structurally better pricing, mix toward advanced products and operating leverage. Higher and expanding EBITA margins support durable profitability even if top-line cycles soften, strengthening cash generation and return on capital.
Resilient Labtech PerformanceLabtech's recurring consumables, tender wins and equipment service mix create stable, high-margin revenue streams. Strong organic growth and improving Labtech margins indicate structural demand in diagnostics/research that supports steady cash and reduces cyclicality over the medium term.
Bears Say
Meaningful Leverage RemainsAlthough leverage has improved, the company still carries notable debt relative to equity and modest coverage of obligations. Persistent leverage constrains strategic flexibility, raises sensitivity to interest costs and makes disciplined cash conversion and targeted deleveraging essential to sustain growth plans.
Working-capital & Inventory TimingVariability in receivables and higher inventories from product rollouts and delivery timing create cash-flow noise that can impede consistent deleveraging and capital allocation. Structural inventory or receivable swings weaken predictability of free cash flow and heighten funding needs during growth or M&A phases.
Reliance On M&A To Sustain GrowthManagement is leaning on bolt-on deals to drive growth, yet recent M&A added limited top-line lift while net debt rose for acquisitions and earnouts. Scaling M&A faster risks execution strain and higher leverage unless cash conversion and integration efficiencies are maintained over time.
AddLife AB News
ADDLF FAQ
What was AddLife AB Class B’s price range in the past 12 months?
AddLife AB Class B lowest stock price was $11.75 and its highest was $24.52 in the past 12 months.
What is AddLife AB Class B’s market cap?
AddLife AB Class B’s market cap is $1.98B.
When is AddLife AB Class B’s upcoming earnings report date?
AddLife AB Class B’s upcoming earnings report date is Oct 21, 2026 which is in 88 days.
How were AddLife AB Class B’s earnings last quarter?
AddLife AB Class B released its earnings results on Jul 16, 2026. The company reported $0.111 earnings per share for the quarter, beating the consensus estimate of $0.109 by $0.002.
Is AddLife AB Class B overvalued?
According to Wall Street analysts AddLife AB Class B’s price is currently Undervalued.
Does AddLife AB Class B pay dividends?
AddLife AB Class B pays a Annually dividend of $0.163 which represents an annual dividend yield of 0.39%. See more information on AddLife AB Class B dividends here
What is AddLife AB Class B’s EPS estimate?
AddLife AB Class B’s EPS estimate is 0.09.
How many shares outstanding does AddLife AB Class B have?
AddLife AB Class B has 117,877,460 shares outstanding.
What happened to AddLife AB Class B’s price movement after its last earnings report?
AddLife AB Class B reported an EPS of $0.111 in its last earnings report, beating expectations of $0.109. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AddLife AB Class B?
Currently, no hedge funds are holding shares in ADDLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AddLife AB Class B
AddLife AB (publ), a company established in 1906 and headquartered in Stockholm, Sweden, specializes in delivering cutting-edge equipment, medical apparatus, and chemical reagents. Its primary clientele includes the healthcare sector, academic and research organizations (such as colleges and universities), and key players within the food and pharmaceutical industries. The firm's operations are divided into two distinct divisions: Labtech and Medtech. The Labtech segment provides a comprehensive array of products, integrated solutions, and expert services, focusing on diagnostics, biomedical research, and general laboratory requirements. This encompasses specialized instruments for areas like haematology, pathology, immediate diagnostic testing (point-of-care), cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, along with consumables and advanced analytical machinery. This division further offers vital support, maintenance, consultancy, and educational programs. Conversely, the Medtech segment concentrates on supplying a wide range of medical devices tailored for critical applications such as surgical procedures, respiratory support, intensive care, wound management, and enteral nutrition. It also develops products for fall prevention, welfare technology, and ear, nose, and throat conditions, in addition to offering specific assistive devices for bathrooms and specialized aids for children with disabilities. AddLife maintains a broad international presence, conducting business in its home country of Sweden, across the Nordics (Finland, Denmark, Norway), the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, other parts of Europe, and globally.
ADDLF Stock 12 Month Forecast
Average Price Target
$16.92
▲(0.68% Upside)
Technical Analysis
Ownership Overview
―
Insiders
11.17% Mutual Funds
― Other Institutional Investors
84.57% Public Companies and
Individual Investors